Overview

Effect of Itraconazole on the Pharmacokinetics of Apatinib

Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
he primary purpose of this study is to investigate potential pharmacokinetic interaction in healthy volunteers when apatinib is administered in combination with itraconazole. Secondary objective is evaluating the safety and tolerability of apatinib alone and when co-administered with itraconazole.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Apatinib
Hydroxyitraconazole
Itraconazole